Latest Audit News

La Trobe Financial’s 12-trust annual report shows continued expansion in its residential mortgage-backed securities platform, with cumulative losses of 0.03% of original issuance since 2014. The group also completed a further $1.25 billion RMBS transaction after year-end, while liquidity usage and newer loan pools remain key areas to monitor.

betr Entertainment delivered a 19.1% lift in first-quarter turnover and reaffirmed its FY27 earnings target, but customer-favourable results pushed operating cash flow $6.8 million into the red. Early October trading points to a sharp margin recovery, putting the company's peak-season execution under scrutiny.

South Port has entered FY27 with record full-year earnings behind it and first-quarter cargo volumes still rising, while a new chair takes over during a fresh investment cycle. The port is also preparing to add staff and potentially replace major equipment as regional development opportunities build.

XPON Technologies has completed the Datisan disposal for $8.1 million in initial cash, repaid its short-term loan and redirected its attention to Wondaris and applied AI acquisitions. The company’s next test is whether that cash can translate into stronger platform growth.

Norwood Systems reported A$808,000 in September-quarter customer receipts and positive operating cash flow, but ended the period with only A$14,000 in cash. Its UK and US Tier-1 opportunities advanced towards commercial decisions without yet becoming production contracts.

Jatcorp’s Q1 FY27 revenue fell 52.4% to A$4.66 million as a sharper seasonal downturn in China hit brand sales and OEM orders. Cash fell to A$3.727 million after A$2.145 million of operating outflows, leaving the company’s reported funding estimate at 1.7 quarters.

Singular Health has moved closer to a proposed A$3.5 million Florida Medicaid imaging repository while deploying 1,000 physician licences through its largest customer network. The September quarter also exposed the execution risks ahead, with the Florida MOU still subject to definitive agreements and the PNS contract due for renewal by year-end.

Hydrix reported stronger contract momentum and launched a defence strategy in FY26, but revenue fell, cash burn increased and its statutory loss widened to $6.72 million. The auditor identified a material uncertainty over the company’s ability to continue as a going concern, despite a $5.2 million capital raising and planned debt conversions.

Saunders International says it expects revenue growth and sustained second-half margin improvement in FY27 after reporting record FY26 revenue of A$305.6 million. Its opportunity pipeline reached A$5.1 billion, although converting that pipeline into profitable work remains the central test.

IVE Group’s FY26 revenue slipped 1.8%, but stronger margins lifted underlying pre-AASB 16 NPAT by 3.0% to A$52.5 million and supported a higher final dividend. The marketing and communications group expects underlying pre-AASB 16 profit to be broadly stable in FY27 as new capacity and acquisitions begin to contribute.

The Star Entertainment returned to positive quarterly EBITDA in Q1 FY27, with Sydney and Gold Coast revenue recording year-on-year growth for the first time since quarterly reporting began. The improvement comes alongside negative reported operating cash flow, continuing casino licence restrictions and unresolved going-concern uncertainties.

NeuroScientific Biopharmaceuticals has secured favourable US FDA feedback on its planned StemSmart Phase 2 trial for refractory Crohn’s disease, while appointing a clinical research partner and advancing manufacturing validation. The company enters the next phase with $3.91 million in cash and a targeted trial start by the end of 2026.